Inati-cel

Inaticabtagene Autoleucel

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Inati-cel, covering 2025-01-15 to 2025-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1 [Phase 2]